Vaccines, blood, antisera, toxins and cultures in South Korea | The Observatory of Economic Complexity

About

Exports In 2023, South Korea exported $11.5B in Vaccines, blood, antisera, toxins and cultures, making it the 7th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most exported product in South Korea. The main destination of Vaccines, blood, antisera, toxins and cultures exports from South Korea are: United States ($2.51B), France ($2.31B), Switzerland ($1.55B), Italy ($810M), and Germany ($640M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of South Korea between 2022 and 2023 were France ($2.15B), Switzerland ($412M), and Hungary ($195M).

Imports In 2023, South Korea imported $4.24B in Vaccines, blood, antisera, toxins and cultures, becoming the 17th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 17th most imported product in South Korea. South Korea imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($1.06B), Turkey ($454M), Germany ($444M), Switzerland ($409M), and Netherlands ($359M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for South Korea between 2022 and 2023 were Netherlands ($302M), United Kingdom ($290M), and Sweden ($149M).

COMPANIES In 2024, leading companies such as Amazon (1) and Goodyear Tire and Rubber (1) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from South Korea to the United States.

Latest Trends

January 2025

About

Overview In January 2025 South Korea's Vaccines, blood, antisera, toxins and cultures exports accounted up to $599M and imports accounted up to $278M, resulting in a positive trade balance of $322M. Between January 2024 and January 2025 the exports of South Korea's Vaccines, blood, antisera, toxins and cultures have increased by $142M (31.1%) from $457M to $599M, while imports decreased by $-30.7M (-9.95%) from $308M to $278M.

Destinations In January 2025, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States ($174M), Hungary ($79.1M), Germany ($78.1M), Switzerland ($62.2M), and Netherlands ($37.4M), and were imported mostly from United States ($62.1M), Germany ($38.9M), Ireland ($35.6M), Denmark ($30M), and Turkey ($28.6M).

Growth In January 2025, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Italy ($27.7M or 181%), Germany ($22.6M or 132%), and Poland ($17.9M or 28.5k%). In January 2025, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from United States ($-23.9M or -24.9%), Ireland ($-20.7M or -50.7%), and Turkey ($-14.3M or -34.6%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (January 2024 - January 2025)$142M(31.1%)

IMPORT GROWTH (January 2024 - January 2025)$-30.7M(-9.95%)

MAIN DESTINATION (January 2025)United States$174M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for South Korea. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download